已核实 DOI 相关产品: 6

Oral co-delivery of quercetin and anthocyanins via dual-ligand nanoparticles alleviate obesity and associated metabolic disorders

Journal 2026 · IF 8.8 · 发表于 2026 年 7 月 8 日
作者: Hui Zhang,Chunmei Liu,Jiahao Yang,Shanglin Li,Meng Yang,Jingbo Liu,Ting Zhang,Yajuan Li
阅读全文 在 PubMed 查看

摘要

Dual-ligand nanoparticles enable oral co-delivery of quercetin and anthocyanins. • Core–shell structure provides high encapsulation efficiency and stability. • Nanoparticles enhance intestinal absorption via energy-dependent endocytosis. • Oral NPs surpass atorvastatin in reducing obesity, hepatic steatosis and inflammation. • NPs reshape gut microbiota, enriching beneficial and suppressing harmful bacteria. Obesity is a global epidemic driven in part by poor oral bioavailability of bioactive food compounds. Here, we develop dual-ligand-functionalized nanoparticles (NPs) for the oral co-delivery of hydrophilic anthocyanins (ACN) and hydrophobic quercetin (Que) to combat obesity. The system is assembled from lactobionic acid-modified chitosan (LACS) and glycyrrhetinic acid-modified casein (GACA), forming a core–shell structure that protects both compounds against gastrointestinal degradation and affords pH-responsive colloidal stability. In Caco-2/HT29-MTX-E12 co-culture models, the LACS-ACN-GACA-Que NPs enhance intestinal absorption via energy-dependent endocytosis, facilitate transcellular transport, and achieve sustained intracellular accumulation. Orally administered to high-fat diet-induced obese mice, the NPs surpass both the unencapsulated bioactive mixture and the clinical drug atorvastatin in reducing body weight gain, white adipose tissue hypertrophy, hepatic steatosis, and systemic inflammation. These anti-obesity benefits are accompanied by favorable gut microbiota remodeling: enrichment of short-chain fatty acid-producing taxa ( Oscillospiraceae , Ruminococcaceae , Lachnospiraceae ) and suppression of pro-inflammatory lineages ( Erysipelotrichaceae ). Collectively, this dual-ligand strategy establishes a versatile oral delivery platform that protects and synergistically delivers disparate bioactive compounds, offering a promising approach for obesity management. Download: Download high-res image (361KB) Download: Download full-size image

本研究中使用的阿拉丁产品

6 款产品在本文中被引用